Source: Annual Congress 2011 - Risk assessment for tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
N. T. L. Hang, L. T. Lien, N. Kobayashi, T. Shimbo, S. Sakurada, P. H. Thuong, L. T. Hong, D. B. Tam, M. Hijikata, I. Matsushita, N. V. Hung, K. Higuchi, N. Harada, N. Keicho (Hanoi, Viet Nam; Tokyo, Japan). Unfavorable factors associated with false negative results of interferon-gamma release assay for tuberculosis. Eur Respir J 2011; 38: Suppl. 55, 2662

Member's Comments

No comment yet.

Related content which might interest you: Smoking is a strong independent risk factor for indeterminate and false negative IGRA results Source: Annual Congress 2011 - What is new in tuberculosis immunodiagnosis? Year: 2011 Indeterminate IFN-? release assay test results predict poor prognosis of active pulmonary tuberculosis Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019 Can we predict who will develop TB among those with a positive interferon-? release assay (IGRA)? Source: International Congress 2018 – Important changes in the management of tuberculosis Year: 2018 IFN γ tests for tuberculosis – false positives with other T cell disease processes? Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease Year: 2008 The value of interferon-gamma releasing assays (IGRA) determining latent tuberculosis infection in renal transplant candidates Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Comparison of whole-blood interferon-gamma release assay and tuberculin skin test results for the prediction of active tuberculosis disease in HIV-infected individuals Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009 Clinical evaluation of interferon-gamma release assay (IGRA) in patients with nontuberculous mycobacterial disease Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 No added value of interferon-gamma release to a prediction model for childhood tuberculosis Source: Eur Respir J 2016; 47: 223-232 Year: 2016 False-negative interferon gamma release assay results in active tuberculosis: a TBNET study Source: Eur Respir J 2015; 45: 279-283 Year: 2015 IFN-gamma production in response to RD1 assays correlate with TST size and with the frequency of exposure to the index case in contacts recently exposed to mycobacterium tuberculosis Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007 Basic factors, influencing treatment efficacy of patients with newly detected sputum positive destructive lung tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 724s Year: 2004 Performance outcomes of standardized antigen-driven IFN-g release assays for the diagnosis of active TB in a high burden setting Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease Year: 2008 Do kinetics of interferon-gamma responses predict TB relapse? Source: Annual Congress 2011 - Risk assessment for tuberculosis Year: 2011 Interferon-gamma release assays (IGRA) for latent tuberculosis infection (LTBI) in children Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood Year: 2011 False positive chlamydia pneumonia IgM assay induced by rheumatoid factor Source: Eur Respir J 2006; 28: Suppl. 50, 3s Year: 2006 The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement Source: Eur Respir J 2010; 36: 1185-1206 Year: 2010 Additional analysis of antigen-specific Interleukin-2 release does not improve the performance of IGRAs for the differentiation of different states of mycobacterium tuberculosis infection Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014 Negative effect of ferritin levels on T-SPOT.TB, an enzyme-linked immunospot based interferon-gamma release assay using Mycobacterium tuberculosis specific antigens, in the smear-positive active pulmonary tuberculosis. Source: International Congress 2018 – Diagnosis of tuberculosis Year: 2018 Comparative study of the usefulness of TST and three interferon-gamma release assasys (IGRAs) for the differential diagnosis of pulmonary tuberculosis Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011 Diagnostic performance of the interferon gamma release assay in elderly patients and clinical factors to support the diagnosis of active tuberculosis Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012